A
Acacia sinuata 66
Acalypha indica 66
Acanthosis nigricans P 6
Acetaminophen 55
Acetocopalic acid 43
Acetylsalicylic acid 55
Acremonium species 15
Ageratina pichinchensis lacquer 72
Allylamine derivatives 46
Alpha bisabolol 77
Alpha trans-bergamotol 77
Amides 67
Amino acid 109
Analgesic drugs 54
Anidulafungin 61
Anti-biofilm effects 63
Antibiotic production 67
Antidermatophytic activity 66
Antifungal
action 48
combination of 56
new 95
safety and efficacy of 53
systemic 13
compounds 47
discovery of 50
cream 21
derivative of 64
natural 81
ougon for 50
significant 50
efficacy 45
failures, prevention of 79
groups of 86
itraconazole, systemic 108
luliconazole 84
medication 4
potential of linalool against 48
property 81
resistance 18
in dermatology 55
sensitivity to 8
therapeutic failures 79
therapy 57
topical 13
combination 55
Antimicrobial activity, broad spectrum 52
Antimicrobial agents 52
Antioxidant property 67
Aromatic compound, side-chain 69
Arylazothiazole 69
Arylhydrazothiazole 69
Asparagine 109
B
Bacterial organisms 105
Beta caryophyllene 77
Biosynthesized silver 51
Blood 109
Bullous disorders 80
Burning 22
C
Caffeic acid 68
Candida
in nails 41
isolated 96
lusitaniae 63
new antifungal against 64
resistant 55
strains
different 63
species of 63
Candidal species 64
Candidial infections 61
Capitis favosa patients 5
Carvacrol and thymol 47
Caspofungin 61
Caulerpa sertularioides 28
Causative agents 15
Cellular activities 35
Chemotherapeutic agents 43
Chicago sky blue stain 41
Cibotium barometz 28
Clobetasol 100
Clotrimazole 86
Communicable disease 29
Coniferous resin, natural 72
Constituent copalic acid 43
Copaiba oil 43
Copaifera genus 43
Copalic acid 43
Cutaneous fungi 69
Cutaneous irritation, local 86
Cutaneous protothecosis, course of 105
Cysteine amino acid 53
Cytotoxic T cells 97
D
Dematophytosis, classification of 94
Dermatitis, contact 108
ability of 104
African species of 3
anthropophilic 24
detection of 41
diagnosis of 34
drug-resistant 65
inhibition of 44
isolates 72
clinical 74
multidrug-resistant 65
non 27
penetrate 109
prevalence of 31
related 94
tandem repeat database 95
tested 51
Dermatophytic isolates 110
Dermatophytic nail infection 16
Dermatophytic reinfections 85
chronic 58
diagnosis of 37
diffuse 77
drug-resistant 84
in hosteller, disseminated P 3
mimicking lichen nitidus P 3
of hair, management of 70
predominantly affecting area P 4
prevalence 112
relevance in recalcitrant 45
severe 20
failure in 18
Diabetic and non-diabetic patients 9
Diode laser 13
Dystrophic onychomycosis, total 39
E
Endothrix organism 23
Enzyme 36
Epiglobulol 77
Erythematous itchy 108
Erythroderma 80
Esophageal candidiasis 61
Ethyl cellulose, investigation of 82
Eugenol 47
Ex vivo biofilm-forming 104
Extracellular matrix 57
Eye, nose and mouth, mucocutaneous junctions of P 2
F
Feet-washing behavior 19
Flavonoids 59
Flucytosine 47
Formaldehyde fumigation 85
Fresh patches over healed area P 10
Fungal concentrations 66
Fungal disease 27
Fungal elements 48
Fungal growth 44
anthropophilic 100
chronic 57
coexistence of 91
common 24
diagnosis of 42
effect in 87
invasive 95
management of 70
of feet, management of superficial 85
of hair and nail 70
treatment of 51
Fungal organisms 36
Fungal therapy 82
Fusidic acid 67
G
Glabrous skin 90
Glutamine 109
Glycosidic saponin 47
Glyoxylate cycle 68
Gold nanoparticles 51
Granulomatous diseases 108
Grocott-Gomori's methenamine silver 101
H
Hair follicle 90
Health Education Programs 29
Healthy population, normal 8
Helper T cells 97
Hepatotoxicity 61
Herbal preparations, use of 66
Heterocyclic benzofurans 56
Human cells 35
Human keratinocytes, minimal effect 51
Human pathogenic fungus 52
Human skin equivalents 112
Hydrolytic enzymes 36
I
Ibuprofen 55
Immunomodulatory agents 56
Immunosorbent assay 36
In silico characterization 94
In vitro additive effect 65
In vitro antidermatophytic activity 27
In vitro models 112
In vivo antifungal activity 78
Indocyanine green 39
Inflammation, severe 70
Inflammatory reactions 36
Intralesional steroids 91
Invasive infections, development of 61
Isavuconazole 54
Itching, reduced 22
L
Langerhans cells 97
Laser assisted delivery of topical tazarotene 49
Leg lesion 93
Lichen metabolites 81
Licochalcone 68
Liver enzymes, abnormal 70
Lymphocyte counts 78
Lymphopenia 78
M
Mammalian cells 68
Medicine, traditional 47
Melastoma malabathricum 28
Meloxicam 55
Mentioned 57
Metamizole 55
Methotrexate 93
Methylene blue 39
Micafungin 61
Miconazole 86
Microbiological resistance 56
Mometasone furoate 30
Monolayer cell cultures 112
Mucocutaneous candidiasis 64
Muehlenbeckia platyclada 28
MVAL enzyme 7
Mycosel agar 16
N
Nail
alterations 99
dermatophyte infections, treatments in 58
involvement 91
of psoriasis 91
noninflammatory disorder of 104
plate 71
psoriasis 91
severity of 91
Natural treatments 72
Nitric oxide-releasing drug 12
Nonablative laser 13
Non-albicans species 64
Nonantifungal agents 56
Non-Candida albican species 9
Non-dermatophytic fungi 91
Nondiabetic population 9
Nuclear ribosomal 94
O
Onychomycosis 4, 9, 10, 11, 15, 23, 34, 38, 40, 42, 49, 53, 54, 57, 62, 64, 71, 74, 76, 87, 98, 103, 104
in children 53
treatment of 54
infection 34
cases of 96
pathogens 14
therapy for 57
Oral bioavailability, poor 61
Organ transplant recipients, solid 20
Orocutaneous fungi 8
Ozone application 85
P
PCR-RFLP technique 39
Peltigera praetextata 81
Pemphigus foliaceus group 101
Periodic acid-Schiff 101
Personal hygiene, lack of 29
Phaffia rhodozyma 52
Phenothiazinium dye 40
Phenylalanine 109
Photodynamic treatment with curcumin 44
Photosensitising agents 44
Phyllanthus reticulatus 66
Phylogenetic relation 94
Polyene derivatives 56
Povidone iodine 57
Pramiconazole 58
Proton pump inhibitors 56
Public health problem 87
R
Raman spectroscopy 99
Refractory dermatophytosis 80
Retinoid tazarotene 49
Rezafungin acetate 61
Rhapis excelsa 28
S
Sabouraud's glucose 45
Sanitization powders 85
Scropulariopsis brevicaulis 15
Scutellaria 50
Scytalidium dimidiatum 15
Senna alata 66
Senna auriculata 66
Shoe acts, infected 85
Simvastatin 56
Skin
dermatophyte infections, treatments in 58
dextrose, keratinized 67
disorders 10
fungal infection, risk factors of superficial 29
Spectrum antifungal agent 46
Sterol metabolism 35
Subtilisin gene 110
Sulfones 67
Syzygium myrtifolium 28
T
T cells, types of 97
Tazarotene 49
Tetranortriterpenoid 47
Thiazole derivatives 69
Tinea
coporis with scaling and erosion P 5
folliculorum 90
glutealis P 8
incognito P 9
manuum, retained dermatoglyphics in P 8
of glabrous skin, complicating 90
extensive P 4
in diabetic P 4
in HIV-positive woman, multiple patches of P 5
in infant P 2
in painter mistaken for eczema P 2
in pregnant woman, multiple patches of P 5
inflammatory type of P 2
mimicking
annular erythema P 3
herald patch of pityriasis rosea P 3
psoriasis in patient with psoriasis, plaques of P 2
psoriasis, inflammatory type of P 3
noninflammatory type of P 2
of thigh P 5
of waist with lichenification P 6
over knees in diabetic P 4
with islands of normal skin, extensive P 4
with topical salic acid preparation, eczematisation of P 4
in young boy P 6
unilateral P 7
with active margin P 7
with flexural psoriasis P 7
with postinflammatory pigmentation and active margin P 7
with tinea genitalis P 8
Tinea faciei 24
masquerading atopic dermatitis P 1
mimicking
impetigo circinata P 1
infective eczema P 1
Toenail onychomycoses, clinical laser treatment of 62
Topical therapy, role of 73
Transmission electron microscopy 35
Triamcinolone acetonide 74
equinum 111
erinacei 107
antifungal for 72
complex 107
organisms 52
rubrum 9, 7, 14–16, 18, 27, 28, 31, 32, 39, 40, 42, 43, 46, 48, 50, 51, 59, 60, 65–68, 73, 75, 78, 79, 81, 94, 95, 100, 103, 105, 110
antifungal for 72
cycle of 68
glyoxylate cycle of 68
strains 75
infection, epidemiology of 17
infection 23
Tyrosine 109